JPMorgan analyst Andrea Teixeira upgraded Colgate-Palmolive to Neutral from Underweight and raised her price target for the shares to $70 from $62. The company's organic growth is "finally starting to show consistent improvement," despite mixed signals from most recent scanner data in the U.S., Teixeira tells investors in a research note. For the first time in two years, Colgate-Palmolive delivered both volume and pricing growth when reporting quarterly results on Friday, says the analyst. She notes that while the company's global market share losses on a year-over-year basis are still lingering, its market share has been more stable sequentially.